Open angle glaucoma
Tafluprost is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Tafluprost, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce intraocular pressure by increasing uveoscleral outflow of aqueous humor.
The most frequently reported treatment-related side effect is ocular hyperemia. Rare side effects observed include eye irritation and blurred vision.
Use in pregnancy: Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Tafluprost ophthalmic solution should be used during pregnancy unless the potential benefit justifies the potential risk to the fetus.
Use in lactation: It is not known whether Tafluprost is excreted in human milk. Caution should be exercised while giving this ophthalmic solution to a nursing mother.
- For ophthalmic use only.
- To avoid possible contamination of the drops, do not touch the dropper tip or to any surface.
- Should be used with caution in patients with active intraocular inflammation (e.g., iritis/uveitis).
- If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes between applications.
Use in children: Use in pediatric patients is not recommended.
Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.
Drugs for miotics and glaucoma
Alternative Brand Names
No data was found